Trials / Completed
CompletedNCT05083351
Performance of Masimo MightySat Pulse Oximeter in Differing Levels of Skin Pigmentation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Evaluation of the noninvasive oxygen saturation (SpO2) performance of the noninvasive Masimo MightySat against reference arterial blood samples analyzed by a laboratory CO-oximeter reference instrument. The study will include different subgroups to assess the performance across different genders and skin pigmentation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MightySat | Noninvasive pulse oximeter |
Timeline
- Start date
- 2021-10-13
- Primary completion
- 2021-12-17
- Completion
- 2021-12-17
- First posted
- 2021-10-19
- Last updated
- 2024-09-19
- Results posted
- 2024-09-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05083351. Inclusion in this directory is not an endorsement.